Subcutaneous Furosemide in the Treatment of Patients With Decompensated Heart Failure: Data From the Sub-Q Pilot Studies

Journal of Cardiac Failure - United States
doi 10.1016/j.cardfail.2019.07.213
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Acoustic Speech Analysis of Patients With Decompensated Heart Failure: A Pilot Study

Journal of the Acoustical Society of America
AcousticsUltrasonicsArtsHumanities
2017English

Hemodilution After Initial Treatment in Patients With Acute Decompensated Heart Failure

International Heart Journal
MedicineCardiovascular MedicineCardiology
2018English

Effect of Nesiritide in Patients With Acute Decompensated Heart Failure

New England Journal of Medicine
Medicine
2011English

Care of the Lower Extremities in Patients With Acute Decompensated Heart Failure

Critical Care Nurse
MedicineCritical Care Nursing
2011English

Endothelial Cell Activation in Patients With Decompensated Heart Failure

Circulation
Cardiovascular MedicinePhysiologyCardiology
2005English

Torsemide Versus Furosemide After Acute Decompensated Heart Failure: A Retrospective Observational Study

BMC Cardiovascular Disorders
Cardiovascular MedicineCardiology
2019English

Cognitive Status in Patients Hospitalized With Acute Decompensated Heart Failure

American Heart Journal
Cardiovascular MedicineCardiology
2014English

Role of Ischemia-Modified Albumin in Patients With Acute Decompensated Heart Failure

Anatolian journal of cardiology
Cardiovascular MedicineCardiology
2015English

Difference in Serological Marker Profile of Fontan Patients With Decompensated Heart Failure

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy